Bulltick Wealth Management’s Novo Nordisk NVO Stock Holding History

Bulltick Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.13M	Buy	86,080 +50	+0.1%	+$2.15K	0.84%	38
2026 Q1	$3.26M	Sell	86,030 -19,712	-19%	-$934K	0.72%	40
2025 Q4	$5.38M	Sell	105,742 -52,146	-33%	-$2.67M	1.14%	29
2025 Q3	$8.76M	Buy	157,888 +96,931	+159%	+$5.67M	2.07%	14
2025 Q2	$4.21M	Buy	60,957 +56,974	+1,430%	+$3.88M	1.04%	29
2025 Q1	$281K	Sell	3,983 -2,565	-39%	-$212K	0.07%	107
2024 Q4	$563K	Sell	6,548 -24,650	-79%	-$2.67M	0.13%	90
2024 Q3	$3.71M	Buy	+31,198	New	+$4.16M	0.9%	35

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bulltick Wealth Management's NVO Position: Q2 2026 in Review

Bulltick Wealth Management increased its Novo Nordisk (NVO) stake by 0.06% in Q2 2026, buying an estimated $2.15K and bringing the position to 86,080 shares worth $4.13M. The position accounts for 0.84% of the portfolio, ranked #38.

Bulltick Wealth Management first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $8.76M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Bulltick Wealth Management held 86,080 shares of Novo Nordisk worth $4.13M as of Q2 2026.
Bulltick Wealth Management bought 50 Novo Nordisk shares in Q2 2026, an estimated $2.15K.
Novo Nordisk made up 0.84% of Bulltick Wealth Management's portfolio in Q2 2026, its #38 holding.
Bulltick Wealth Management first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
Bulltick Wealth Management's Novo Nordisk position peaked at $8.76M in Q3 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bulltick Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.